News of Note—Teva accused of shortcutting plant sale; Sun plant gets only one observation

newspapers
(Pixabay)

> Teva has been sued by an Israeli businessman who claims his bid for the land use for two plants the drugmaker is closing in Jerusalem was overlooked. Story

> Sun Pharmaceutical has received on observation during a January FDA inspection of its plant in Halol. Form 483 (PDF)

> Strides says the FDA has approved a new dosage plant in Singapore. Filing (PDF)

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

> Shanghai-based WuXi STA has received EMA approval for a new drug product manufacturing facility in the Waigaoqiao Free Trade Zone of Shanghai. Release

> Lupin has received EU approval for a biologics plant in India. Story

> Cambrex says it has doubled the liquid filling capacity at its plant in Mirabel, Québec. Release

 

Suggested Articles

As a key global ingredient supplier, problems in China can ripple worldwide as they have for Swiss CDMO Lonza.

What challenges continue to plague the pharmaceutical industry for almost a decade? Check out this remarkable innovation in glass science that may be the…

WuXi Biologics says its plant in Wuxi, China, has gotten the go-ahead from the FDA to make HIV drug Trogarzo for TaiMed Biologics.